Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$35.24 - $47.1 $17,020 - $22,749
-483 Reduced 6.0%
7,572 $283,000
Q4 2021

Feb 09, 2022

SELL
$38.07 - $44.87 $41,229 - $48,594
-1,083 Reduced 11.85%
8,055 $343,000
Q3 2021

Nov 12, 2021

BUY
$41.23 - $45.88 $376,759 - $419,251
9,138 New
9,138 $396,000
Q2 2021

Aug 11, 2021

SELL
$38.58 - $44.24 $770,944 - $884,047
-19,983 Closed
0 $0
Q1 2021

May 11, 2021

SELL
$35.27 - $39.67 $716,086 - $805,420
-20,303 Reduced 50.4%
19,983 $772,000
Q4 2020

Feb 16, 2021

SELL
$33.15 - $41.97 $23,901 - $30,260
-721 Reduced 1.76%
40,286 $1.45 Million
Q3 2020

Nov 12, 2020

SELL
$34.44 - $42.23 $179,845 - $220,525
-5,222 Reduced 11.3%
41,007 $1.57 Million
Q1 2020

May 15, 2020

SELL
$25.83 - $45.71 $545,374 - $965,120
-21,114 Reduced 31.35%
46,229 $1.51 Million
Q4 2019

Feb 14, 2020

SELL
$37.87 - $45.37 $201,960 - $241,958
-5,333 Reduced 7.34%
67,343 $3.05 Million
Q3 2019

Nov 13, 2019

SELL
$40.31 - $43.45 $576,191 - $621,074
-14,294 Reduced 16.44%
72,676 $2.96 Million
Q2 2019

Aug 12, 2019

BUY
$34.91 - $42.98 $719,564 - $885,903
20,612 Added 31.06%
86,970 $3.74 Million
Q1 2019

May 08, 2019

BUY
$32.91 - $40.75 $756,864 - $937,168
22,998 Added 53.04%
66,358 $2.55 Million
Q4 2018

Feb 07, 2019

SELL
$31.73 - $39.04 $66,061 - $81,281
-2,082 Reduced 4.58%
43,360 $1.53 Million
Q3 2018

Oct 26, 2018

SELL
$32.83 - $38.63 $1.87 Million - $2.2 Million
-56,983 Reduced 55.63%
45,442 $1.75 Million
Q2 2018

Aug 03, 2018

BUY
$26.84 - $34.32 $1.07 Million - $1.37 Million
39,904 Added 63.82%
102,425 $3.35 Million
Q4 2017

Feb 08, 2018

BUY
$24.79 - $29.8 $1.17 Million - $1.41 Million
47,200 Added 308.07%
62,521 $1.55 Million
Q2 2017

Aug 15, 2017

SELL
N/A
-29,200 Reduced 65.59%
15,321 $425,000
Q2 2017

Aug 14, 2017

BUY
N/A
44,521
44,521 $0

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Barings LLC Portfolio

Follow Barings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Barings LLC with notifications on news.